Amgen

Source: www.cnbc.com --- 5 days ago
   Posted By:Mike HuckmanWhen combing through Barron's over the weekend I always make it a point to check out the "Short Interest" tables when they appear. I'm curious, in particular, about the ups and downs in Dendreon. Right now it's 39th on Barron's list of the Top-40 largest short positions. Read More Topics:Stock Market | Medicine | PharmaceuticalsSectors:Health Care Equipment and Services | Health Care | PharmaceuticalsCompanies:Sun Microsystems Inc | Dendreon Corp | Amgen IncMEDIA:PHOTO Permalink ...

Source: articles.moneycentral.msn.com --- 2 days ago
...

Source: articles.moneycentral.msn.com --- 5 days ago
NEW YORK (AP) - In a June 26 story on drug maker Amgen, The Associated Press reported that a doctor who ran trials on the Amgen drug denosumab believes an issue with infections could keep the drug from being approved by regulators. ...

Source: articles.moneycentral.msn.com --- 8 days ago
NEW YORK (AP) - Amgen's experimental osteoporosis drug denosumab could have difficulty gaining Food and Drug Administration approval in its initial try, due to a higher incidence of infections compared with placebo seen in some patients, according to an osteoporosis doctor who conducted clinical trials for Amgen. ...

Source: articles.moneycentral.msn.com --- 18 days ago
WASHINGTON (AP) - Federal regulators said Monday an Amgen drug used to treat a severe skin disorder was associated with sometimes lethal infections when used in children. ...

Source: articles.moneycentral.msn.com --- 23 days ago
WASHINGTON (AP) - Maxygen Inc. warned Friday that Amgen Inc. may sue the company for patent infringement relating to Maxygen's Maxy-G34 drug candidate. ...

Source: articles.moneycentral.msn.com --- 14 days ago
...

Source: articles.moneycentral.msn.com --- 23 days ago
NEW YORK (AP) - Shares of Maxygen Inc. plunged 27 percent Friday, after the biotechnology company said it may be open to patent infringement litigation from rival Amgen Inc. ...

Source: articles.moneycentral.msn.com --- 16 days ago
Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today issued the following statement on the outcome of todays meeting of the U.S. Food and Drug Administrations (FDA) ...

Source: articles.moneycentral.msn.com --- 25 days ago
Amgen (NASDAQ:AMGN) Senior Vice President of North American Commercial Operations James Daly will present at the Goldman Sachs Healthcare Conference on Wednesday, June 11, 2008 beginning at 8:40 ...

Source: articles.moneycentral.msn.com --- 30 days ago
Amgen (NASDAQ:AMGN) today announced the 32 science teachers across the United States (U.S.), Canada and Puerto Rico who are this years recipients of the Amgen Award for Science Teaching Excellence, ...

Source: articles.moneycentral.msn.com --- 10 days ago
...

Source: articles.moneycentral.msn.com --- 34 days ago
Amgen (NASDAQ: AMGN) today announced results from three denosumab studies in cancer patients. A Phase 2 study of metastatic patients previously treated with IV bisphosphonates found that denosumab ...

Source: articles.moneycentral.msn.com --- 34 days ago
Amgen (NASDAQ:AMGN) today announced interim results from four of the company's investigational cancer agents. Data presented from trials with recombinant human (rh) Apo2L/TRAIL, AMG 479, AMG 102 and ...

Source: www.reuters.com --- 20 days ago
WASHINGTON (Reuters) - Post-marketing reports of life-threatening complications in children given Amgen Inc's drug Enbrel for psoriasis are 'concerning,' U.S. Food and Drug Administration staff said in documents released on Monday. ...

Source: blog.seattlepi.nwsource.com --- 16 days ago
When I last wrote about Amgen's Denosumab (the company's best hope for another blockbuster) I mentioned that an oncology team in Seattle had been working on the drug's development for the last 13 years. ...

Source: www.moreover.com --- 34 days ago
Street Insider Jun 2 2008 12:21PM GMT ...

Source: www.moreover.com --- 23 days ago
Yahoo! Canada Jun 13 2008 10:19AM GMT ...

Source: www.moreover.com --- 20 days ago
Yahoo! Canada Jun 16 2008 2:52PM GMT ...

Source: clientportal.ibb.ubs.com --- 17 hours ago
This document is related to the following: Regions Global Americas United States North America Sectors Global Biotechnology Global Healthcare US Biotechnology Americas Biotechnology Americas Healthcare US Healthcare North American Biotechnology North American Healthcare Companies AMGN.O Amgen Subjects Morning Note ...